Cellectar Biosciences Inc... (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.27

0.01 (2.20%)

At close: May 02, 2025, 3:59 PM

0.27

-0.04%

After-hours: May 02, 2025, 05:05 PM EDT

Cellectar Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-44.58M	-37.98M	-28.6M	-24.12M	-15.09M	-14.09M	-13.24M	-13.56M	-6.18M
Depreciation & Amortization	291.65K	192.38K	148.44K	149.91K	141.45K	132.8K	82.27K	1.55M	356.67K
Stock-Based Compensation	4.27M	2.41M	1.45K	1.12K	467.54	866.79	721.21K	758.76K	529.16K
Other Working Capital	-132.42K	-224.39K	60.21K	-212.96K	-109.36K	266K	-310.26K	-192.07K	-466.7K
Other Non-Cash Items	-5.84M	-471.95K	93.82K	77.72K	66.48K	56.56K	1.56M	-22.07K	529.16K
Deferred Income Tax	n/a	n/a	n/a	2.94K	-185.28K	-43K	n/a	n/a	-3.79M
Change in Working Capital	-1.73M	3.48M	1.68M	198.76K	671.24K	1.39M	-569.05K	259.26K	273.81K
Operating Cash Flow	-47.58M	-32.38M	-25.22M	-22.57M	-13.93M	-11.69M	-11.44M	-11.02M	-8.28M
Capital Expenditures	-104.19K	-864.04K	-225.97K	-141.36K	-62.35K	-24.54K	-384.99K	-346.7K	-72.25K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	55K	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	55K	n/a	n/a
Investing Cash Flow	-104.19K	-864.04K	-225.97K	-141.36K	-62.35K	-24.54K	-329.99K	-346.7K	-72.25K
Debt Repayment	n/a	n/a	n/a	n/a	184K	-2.21K	-3.04K	-89.32K	-246.08K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-2.24M	-1.45M	n/a
Other Financial Acitivies	61.41M	789.64K	-9.61M	1.21M	642.5K	n/a	-762	4.3M	363.78K
Financial Cash Flow	61.41M	22.94M	9.61M	1.25M	60.55M	9.02M	15.02M	9.93M	15.94M
Net Cash Flow	13.72M	-10.3M	-15.84M	-21.46M	46.55M	-2.7M	3.25M	-1.44M	7.59M
Free Cash Flow	-47.69M	-33.24M	-25.45M	-22.71M	-14M	-11.72M	-11.83M	-11.37M	-8.35M